perflutren has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalkader, R; Hashida, M; Kawakami, S; Maruyama, K; Suzuki, R; Unga, J; Yamashita, F | 1 |
| Fleischer, AC; Hallahan, DE; Huamani, J; Kim, DW; Niermann, KJ; Wilson, WD; Yankeelov, TE | 1 |
| Carson, PL; Fowlkes, JB; Gardner, EA; Ivey, JA; Rhee, RT; Rubin, JM; Sirkin, DW | 1 |
3 other study(ies) available for perflutren and Experimental Neoplasms
| Article | Year |
|---|---|
Evaluation of the potential of doxorubicin loaded microbubbles as a theranostic modality using a murine tumor model.
Topics: Animals; Antibiotics, Antineoplastic; Capsules; Cell Line, Tumor; Contrast Media; Diffusion; Doxorubicin; Drug Monitoring; Female; Fluorocarbons; High-Energy Shock Waves; Mice; Mice, Inbred C57BL; Microbubbles; Neoplasms, Experimental; Treatment Outcome; Ultrasonography | 2015 |
Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
Topics: Animals; Cell Line, Tumor; Contrast Media; Fluorocarbons; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neovascularization, Pathologic; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ultrasonography | 2007 |
Transcutaneous interruption of ultrasound contrast agents for blood flow evaluation.
Topics: Animals; Carcinoma; Contrast Media; Drug Carriers; Female; Femoral Artery; Fluorocarbons; Infusions, Intravenous; Liposomes; Neoplasms, Experimental; Rabbits; Regional Blood Flow; Software; Thigh; Time Factors; Ultrasonography, Doppler, Color | 1998 |